Design and implementation of the North American Pediatric Cardiomyopathy Registry.

The Pediatric Cardiomyopathy Registry (PCMR) was established to describe the epidemiologic features and clinical course of selected cardiomyopathies in patients aged 18 years or younger and to promote the development of etiology-specific treatments. Sixty-one private and institutional pediatric cardiomyopathy practices in the United States and Canada were recruited to participate in the PCMR. The registry consists of a prospective, population-based cohort of patients in 2 regions (New England and the Central Southwestern United States) and a retrospective cohort of patients diagnosed between 1991 and 1996. Annual follow-up data are collected on all patients. As of June 1999, the PCMR consisted of 337 prospectively identified and 990 retrospectively identified patients. The PCMR has demonstrated the feasibility of establishing a large database of sociodemographic and clinical information on children with pediatric cardiomyopathy. Through this cooperative effort, the PCMR will obtain precise estimates of the incidence of pediatric cardiomyopathy and a better understanding of the natural history of this disease.

[1]  R. Gillum Idiopathic cardiomyopathy in the United States, 1970-1982. , 1986, American heart journal.

[2]  S. Nouri,et al.  Clinical profile of conjestive cardiomyopathy in children , 1990 .

[3]  S. Lipshultz,et al.  Clinical approach to genetic cardiomyopathy in children. , 1996, Circulation.

[4]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[5]  S. Berger,et al.  Sudden cardiac death in infants, children, and adolescents. , 1999, Pediatric clinics of North America.

[6]  J. Steiner,et al.  Chart reviews in emergency medicine research: Where are the methods? , 1996, Annals of emergency medicine.

[7]  O. Ruuskanen,et al.  Idiopathic Dilated Cardiomyopathy in Children: Prognostic Indicators and Outcome , 1998, Pediatrics.

[8]  T. Spray,et al.  Dilated cardiomyopathy in infants and children. , 1988, Journal of the American College of Cardiology.

[9]  R. Doughty,et al.  Epidemiology of heart failure and ventricular dysfunction , 1998, The Lancet.

[10]  A. Keogh,et al.  Timing of cardiac transplantation in idiopathic dilated cardiomyopathy. , 1988, The American journal of cardiology.

[11]  A. Nadas,et al.  The clinical course of primary myocardial disease in infants and children. , 1976, American heart journal.

[12]  W. Stevenson,et al.  Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. , 1987, The American journal of medicine.

[13]  A. Lewis,et al.  Outcome of infants and children with dilated cardiomyopathy. , 1991, The American journal of cardiology.

[14]  L N J Archer,et al.  Heart Disease in Infants, Children and Adolescents including the Fetus and Young Adult , 1996 .

[15]  S. Colan,et al.  Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. , 1992, Journal of the American College of Cardiology.

[16]  B. McCrindle,et al.  Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[17]  S. Lipshultz,et al.  Pediatric Dilated Cardiomyopathy (DCM): Prognosis in a developing nation is comparable to developed nations , 1996 .

[18]  R. Friedman,et al.  Clinical course of idiopathic dilated cardiomyopathy in children. , 1991, Journal of the American College of Cardiology.

[19]  H. Krumholz Time to focus on the more typical heart-failure patients , 1998, The Lancet.

[20]  J. Matthews,et al.  Prognostic features of children with idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.

[21]  Arthur J. Moss,et al.  Moss and Adams' heart disease in infants, children, and adolescents : including the fetus and young adult , 2016 .

[22]  R. Rowe,et al.  Natural history and prognostic risk factors in endocardial fibroelastosis. , 1988, The American journal of cardiology.

[23]  O. Simell,et al.  Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.

[24]  L. Benson,et al.  Natural history of dilated cardiomyopathy in children. , 1991, American heart journal.

[25]  J. Cordero Registries of birth defects and genetic diseases. , 1992, Pediatric clinics of North America.

[26]  J. Seward,et al.  Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. , 1985, Journal of the American College of Cardiology.

[27]  D. Fyler,et al.  Nadas' Pediatric Cardiology , 1992 .